A citation-based method for searching scientific literature

Sanjay Kalra, Kimi K Shetty, Vertivel B Nagarajan, Jignesh K Ved.  2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control.
Young-Sun Lee, Hee-Sook Jun. Mediators Inflamm. 2016
76
50

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil McEwan, Umesh Dashora.  2020
4
50

COVID-19 and diabetes: Can DPP4 inhibition play a role?
Gianluca Iacobellis. Diabetes Res Clin Pract 2020
86
50

Why are pregnant women susceptible to COVID-19? An immunological viewpoint.
Hong Liu, Li-Ling Wang, Si-Jia Zhao, Joanne Kwak-Kim, Gil Mor, Ai-Hua Liao. J. Reprod. Immunol. 2020
50
50



DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
120
50

NF-κB signaling in inflammation.
Ting Liu, Lingyun Zhang, Donghyun Joo, Shao-Cong Sun. Signal Transduct Target Ther 2017
705
50

A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers.
Azka Ali, Alejandra Fuentes, William Paul Skelton, Yu Wang, Susan McGorray, Chintan Shah, Rohit Bishnoi, Long H Dang, Nam H Dang.  2019
4
50


Clinical Characteristics of COVID-19 Patients With Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study.
Lei Pan, Mi Mu, Pengcheng Yang, Yu Sun, Runsheng Wang, Junhong Yan, Pibao Li, Baoguang Hu, Jing Wang, Chao Hu,[...]. Am. J. Gastroenterol. 2020
300
50

Endothelial cell infection and endotheliitis in COVID-19.
Zsuzsanna Varga, Andreas J Flammer, Peter Steiger, Martina Haberecker, Rea Andermatt, Annelies S Zinkernagel, Mandeep R Mehra, Reto A Schuepbach, Frank Ruschitzka, Holger Moch. Lancet 2020
927
50

Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis.
Christian Hampp, Richard S Swain, Casie Horgan, Elizabeth Dee, Yandong Qiang, Sarah K Dutcher, Andrew Petrone, Rong Chen Tilney, Judith C Maro, Catherine A Panozzo. Diabetes Care 2020
7
50


A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury.
Keiji Kuba, Yumiko Imai, Shuan Rao, Hong Gao, Feng Guo, Bin Guan, Yi Huan, Peng Yang, Yanli Zhang, Wei Deng,[...]. Nat. Med. 2005
50


The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Wen Zhang, Yan Zhao, Fengchun Zhang, Qian Wang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Xuan Zhang, Xiaowei Yan,[...]. Clin. Immunol. 2020
304
50

COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Luca Spiezia, Annalisa Boscolo, Francesco Poletto, Lorenzo Cerruti, Ivo Tiberio, Elena Campello, Paolo Navalesi, Paolo Simioni. Thromb. Haemost. 2020
145
50

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Ka Shing Cheung, Ivan F N Hung, Pierre P Y Chan, K C Lung, Eugene Tso, Raymond Liu, Y Y Ng, Man Y Chu, Tom W H Chung, Anthony Raymond Tam,[...]. Gastroenterology 2020
215
50



Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou, Lanying Du. Cell Mol Immunol 2020
233
50

Coagulation abnormalities and thrombosis in patients with COVID-19.
Marcel Levi, Jecko Thachil, Toshiaki Iba, Jerrold H Levy. Lancet Haematol 2020
171
50

DPP-4 Inhibitor-Related Pancreatitis: Rare but Real!
J Hans DeVries, Julio Rosenstock. Diabetes Care 2017
15
50

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Giacomo Grasselli, Alberto Zangrillo, Alberto Zanella, Massimo Antonelli, Luca Cabrini, Antonio Castelli, Danilo Cereda, Antonio Coluccello, Giuseppe Foti, Roberto Fumagalli,[...]. JAMA 2020
980
50

DPP-4 inhibitors and risk of infections: a meta-analysis of randomized controlled trials.
Wenjia Yang, Xiaoling Cai, Xueyao Han, Linong Ji. Diabetes Metab. Res. Rev. 2016
18
50

DPP4-directed therapeutic strategies for MERS-CoV.
Dirk Reinhold, Stefan Brocke. Lancet Infect Dis 2014
8
50

Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.
Makoto Ayaori, Naotsugu Iwakami, Harumi Uto-Kondo, Hiroki Sato, Makoto Sasaki, Tomohiro Komatsu, Maki Iizuka, Shunichi Takiguchi, Emi Yakushiji, Kazuhiro Nakaya,[...]. J Am Heart Assoc 2013
83
50


SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells.
T J Lin, T B Issekutz, J S Marshall. Int. Arch. Allergy Immunol. 2001
25
50

Sex differences in immune responses.
Sabra L Klein, Katie L Flanagan. Nat. Rev. Immunol. 2016
748
50

Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control.
Eleonora Palella, Rossella Cimino, Salvatore A Pullano, Antonino S Fiorillo, Elio Gulletta, Antonio Brunetti, Daniela P Foti, Marta Greco. Int J Environ Res Public Health 2020
7
50

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
V Stalin Raj, Huihui Mou, Saskia L Smits, Dick H W Dekkers, Marcel A Müller, Ronald Dijkman, Doreen Muth, Jeroen A A Demmers, Ali Zaki, Ron A M Fouchier,[...]. Nature 2013
789
50

A dipeptidyl peptidase-4 inhibitor ameliorates hypertensive cardiac remodeling via angiotensin-II/sodium-proton pump exchanger-1 axis.
Haruya Kawase, Yasuko K Bando, Kazuyuki Nishimura, Morihiko Aoyama, Akio Monji, Toyoaki Murohara. J. Mol. Cell. Cardiol. 2016
13
50

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.
Jia Liu, Ruiyuan Cao, Mingyue Xu, Xi Wang, Huanyu Zhang, Hengrui Hu, Yufeng Li, Zhihong Hu, Wu Zhong, Manli Wang.  2020
537
50


Prevalence and impact of diabetes among people infected with SARS-CoV-2.
G P Fadini, M L Morieri, E Longato, A Avogaro. J. Endocrinol. Invest. 2020
85
50

Angiotensin-converting enzyme 2 in acute respiratory distress syndrome.
Y Imai, K Kuba, J M Penninger. Cell. Mol. Life Sci. 2007
48
50

Is there a Chance to Promote Arteriogenesis by DPP4 Inhibitors Even in Type 2 Diabetes? A Critical Review.
Srinivasan Vedantham, Anna-Kristina Kluever, Elisabeth Deindl. Cells 2018
4
50


Impact of DPP-4 inhibition on acute and chronic endothelial function in humans with type 2 diabetes on background metformin therapy.
Michael E Widlansky, Venkata K Puppala, Tisha M Suboc, Mobin Malik, Amberly Branum, Kara Signorelli, Jingli Wang, Rong Ying, Michael J Tanner, Sudhi Tyagi. Vasc Med 2017
11
50

Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy.
Eusebio Chiefari, Carmelo Capula, Ada Vero, Rosa Oliverio, Luigi Puccio, Rossella Liguori, Vittorio Pullano, Manfredi Greco, Daniela Foti, Domenico Tirinato,[...]. Diabetes Technol. Ther. 2015
8
50

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study.
Seoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, Michael Doherty, Allison B Goldfine, Daniel H Solomon. Ann. Rheum. Dis. 2015
40
50

SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons?
Dario Pitocco, Linda Tartaglione, Luca Viti, Mauro Di Leo, Alfredo Pontecorvi, Salvatore Caputo. Diabetes Res. Clin. Pract. 2020
7
50

Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study.
François Bénézit, Paul Loubet, Florence Galtier, Charlotte Pronier, Nezha Lenzi, Zineb Lesieur, Stéphane Jouneau, Gisèle Lagathu, Anne-Sophie L'Honneur, Vincent Foulongne,[...]. Infection 2020
3
50

Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats.
Marina Romaní-Pérez, Verónica Outeiriño-Iglesias, Christian M Moya, Pilar Santisteban, Lucas C González-Matías, Eva Vigo, Federico Mallo. Endocrinology 2015
63
50

Clinical considerations for patients with diabetes in times of COVID-19 epidemic.
Ritesh Gupta, Amerta Ghosh, Awadhesh Kumar Singh, Anoop Misra. Diabetes Metab Syndr 2020
121
50

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes.
Maria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, Biagio Arcidiacono, Domenica Maria Corigliano, Stefania Giuliano, Francesco Saverio Brunetti, Sinan Tanyolaç, Daniela Patrizia Foti, Luigi Puccio,[...]. Int J Environ Res Public Health 2019
4
50

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.
Cynthia Magro, J Justin Mulvey, David Berlin, Gerard Nuovo, Steven Salvatore, Joanna Harp, Amelia Baxter-Stoltzfus, Jeffrey Laurence. Transl Res 2020
428
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.